Related Experiment Video
Updated: Jul 11, 2026

08:19
Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
Published on: June 1, 2012
Rectangular cymbal arrays for improved ultrasonic transdermal insulin delivery
Joseph Luis1, Eun Joo Park, Richard J Meyer
1Graduate Program in Acoustics, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.
The Journal of the Acoustical Society of America
|October 2, 2007
Summary
A new rectangular cymbal ultrasound array improved insulin delivery more effectively than a circular array in hyperglycemic rabbits. This novel rectangular design offers enhanced therapeutic efficiency for transdermal drug delivery applications.
Area of Science:
- Biomedical Engineering
- Ultrasound Technology
- Pharmacology
Background:
- Circular cymbal ultrasound arrays have demonstrated efficacy in transdermal insulin delivery across multiple animal models.
- Improving delivery efficiency is crucial for therapeutic applications, necessitating novel device designs.
- Rectangular cymbal arrays offer potential for broader spatial intensity fields without increasing device size or peak intensity.
Purpose of the Study:
- To evaluate the performance of a 3x1 rectangular cymbal ultrasound array compared to a 3x3 circular array for glucose reduction in hyperglycemic rabbits.
- To determine if the rectangular design offers significantly improved transdermal insulin delivery efficiency.
Main Methods:
- Hyperglycemic rabbits were divided into three groups: control (no sonication), circular array sonication, and rectangular array sonication.
- Insulin was delivered via a reservoir attached to the rabbit's thigh, with blood glucose levels monitored over 90 minutes.
- Blood glucose levels were normalized to baseline for inter-animal comparison.
Main Results:
- The control group showed an increase in normalized glucose levels (+80.0+/-28.8 mg/dL).
- The circular array resulted in a glucose decrease to -146.7+/-17.8 mg/dL at 90 minutes.
- The rectangular cymbal array demonstrated a faster and greater glucose reduction, reaching -200.8+/-5.9 mg/dL after 90 minutes.
Conclusions:
- The rectangular cymbal ultrasound array is a feasible and improved device for transdermal drug delivery.
- This novel design enhances therapeutic efficiency for glucose reduction in hyperglycemic models.
- Further research into rectangular cymbal arrays could advance ultrasound-mediated drug delivery systems.

